JP Morgan Chase’s NantHealth, Inc NH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1
| Closed | – | – | 7579 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 7546 |
|
|
2022
Q4 | $0 | Sell |
1
-2
| -67% | -$9 | ﹤0.01% | 7304 |
|
|
2022
Q3 | $0 | Sell |
3
-12
| -80% | -$85 | ﹤0.01% | 7096 |
|
|
2022
Q2 | $0 | Sell |
15
-829
| -98% | -$7.74K | ﹤0.01% | 7140 |
|
|
2022
Q1 | $10K | Sell |
844
-1,215
| -59% | -$15.5K | ﹤0.01% | 6219 |
|
|
2021
Q4 | $33K | Sell |
2,059
-11,639
| -85% | -$246K | ﹤0.01% | 6089 |
|
|
2021
Q3 | $331K | Sell |
13,698
-3,481
| -20% | -$105K | ﹤0.01% | 4964 |
|
|
2021
Q2 | $599K | Sell |
17,179
-90
| -0.5% | -$3.58K | ﹤0.01% | 4588 |
|
|
2021
Q1 | $831K | Buy |
17,269
+8,073
| +88% | +$468K | ﹤0.01% | 4365 |
|
|
2020
Q4 | $446K | Buy |
9,196
+7,142
| +348% | +$269K | ﹤0.01% | 4434 |
|
|
2020
Q3 | $71K | Buy |
2,054
+595
| +41% | +$33.5K | ﹤0.01% | 4840 |
|
|
2020
Q2 | $101K | Sell |
1,459
-6,424
| -81% | -$256K | ﹤0.01% | 4577 |
|
|
2020
Q1 | $188K | Buy |
+7,883
| New | +$189K | ﹤0.01% | 4293 |
|
|
2019
Q3 | – | Sell |
-25
| Closed | – | – | 6048 |
|
|
2019
Q2 | $0 | Sell |
25
-19,967
| -100% | -$203K | ﹤0.01% | 6102 |
|
|
2019
Q1 | $276K | Sell |
19,992
-4,972
| -20% | -$57.6K | ﹤0.01% | 4481 |
|
|
2018
Q4 | $204K | Buy |
24,964
+24,648
| +7,800% | +$432K | ﹤0.01% | 4593 |
|
|
2018
Q3 | $7K | Buy |
316
+39
| +14% | +$1.48K | ﹤0.01% | 5540 |
|
|
2018
Q2 | $14K | Buy |
277
+64
| +30% | +$3.17K | ﹤0.01% | 5343 |
|
|
2018
Q1 | $10K | Sell |
213
-446
| -68% | -$22.4K | ﹤0.01% | 5170 |
|
|
2017
Q4 | $30K | Buy |
+659
| New | +$34.9K | ﹤0.01% | 5069 |
|
|
2017
Q1 | – | Sell |
-768
| Closed | -$114K | – | 5294 |
|
|
2016
Q4 | $114K | Buy |
768
+547
| +248% | +$96.8K | ﹤0.01% | 4363 |
|
|
2016
Q3 | $44K | Buy |
+221
| New | +$40.7K | ﹤0.01% | 4068 |
|
JP Morgan Chase's NH Position: Q2 2023 in Review
JP Morgan Chase sold out of NantHealth, Inc (NH) in Q2 2023, closing a stake of 1 share.
JP Morgan Chase first reported a position in NH in Q3 2016 and held it in 22 quarters. The position peaked at $831K in Q1 2021. 0 funds tracked by Wall St. Rank hold NH as of Q2 2023.
- JP Morgan Chase reported no remaining NantHealth, Inc position as of Q2 2023 after selling out during the quarter.
- JP Morgan Chase sold 1 NantHealth, Inc share in Q2 2023.
- JP Morgan Chase first reported a position in NantHealth, Inc in Q3 2016 and held it in 22 quarters.
- JP Morgan Chase's NantHealth, Inc position peaked at $831K in Q1 2021.
- 0 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2023.
Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.